Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Robert Kyle

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Concepts & Ideas

Physiology

Disease Progression

Chemicals & Drugs

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Lacy Martha Q; Hayman Suzanne R; Gertz Morie A; Dispenzieri Angela; Buadi Francis; Kumar Shaji; Greipp Philip R; Lust John A; Russell Stephen J; Dingli David; Kyle Robert A; Fonseca Rafael; Bergsagel P Leif; Roy Vivek; Mikhael Joseph R; Stewart A Keith; Laumann Kristina; Allred Jacob B; Mandrekar Sumithra J; Rajkumar S Vincent
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.
Chee Cheng E; Kumar Shaji; Larson Dirk R; Kyle Robert A; Dispenzieri Angela; Gertz Morie A; Colby Colin L; Rajkumar S Vincent
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma.
Kyle Robert A; Rajkumar S Vincent
Treatment of multiple myeloma: a comprehensive review.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Kyle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lacy Martha Q; Hayman Suzanne R; Gertz Morie A; Dispenzieri Angela; Buadi Francis; Kumar Shaji; Greipp Philip R; Lust John A; Russell Stephen J; Dingli David; Kyle Robert A; Fonseca Rafael; Bergsagel P Leif; Roy Vivek; Mikhael Joseph R; Stewart A Keith; Laumann Kristina; Allred Jacob B; Mandrekar Sumithra J; Rajkumar S Vincent
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5008-14.
2009: Chee Cheng E; Kumar Shaji; Larson Dirk R; Kyle Robert A; Dispenzieri Angela; Gertz Morie A; Colby Colin L; Rajkumar S Vincent
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma.
Blood 2009;114(13):2617-8.
2009: Kyle Robert A; Rajkumar S Vincent
Treatment of multiple myeloma: a comprehensive review.
Clinical lymphoma & myeloma 2009;9(4):278-88.
2009: Bida John P; Kyle Robert A; Therneau Terry M; Melton L Joseph; Plevak Matthew F; Larson Dirk R; Dispenzieri Angela; Katzmann Jerry A; Rajkumar S Vincent
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.
Mayo Clinic proceedings. Mayo Clinic 2009;84(8):685-93.
2009: Katzmann Jerry A; Kyle Robert A; Benson Joanne; Larson Dirk R; Snyder Melissa R; Lust John A; Rajkumar S Vincent; Dispenzieri Angela
Screening panels for detection of monoclonal gammopathies.
Clinical chemistry 2009;55(8):1517-22.
2009: Hari P N; Zhang M-J; Roy V; Pérez W S; Bashey A; To L B; Elfenbein G; Freytes C O; Gale R P; Gibson J; Kyle R A; Lazarus H M; McCarthy P L; Milone G A; Pavlovsky S; Reece D E; Schiller G; Vela-Ojeda J; Weisdorf D; Vesole D
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(8):1528-34.
2009: Rubio-Tapia Alberto; Kyle Robert A; Kaplan Edward L; Johnson Dwight R; Page William; Erdtmann Frederick; Brantner Tricia L; Kim W Ray; Phelps Tara K; Lahr Brian D; Zinsmeister Alan R; Melton L Joseph; Murray Joseph A
Increased prevalence and mortality in undiagnosed celiac disease.
Gastroenterology 2009;137(1):88-93.
2009: Kapoor Prashant; Kumar Shaji; Fonseca Rafael; Lacy Martha Q; Witzig Thomas E; Hayman Suzanne R; Dispenzieri Angela; Buadi Francis; Bergsagel P Leif; Gertz Morie A; Dalton Robert J; Mikhael Joseph R; Dingli David; Reeder Craig B; Lust John A; Russell Stephen J; Roy Vivek; Zeldenrust Steven R; Stewart A Keith; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood 2009;114(3):518-21.
2009: Vachon Celine M; Kyle Robert A; Therneau Terry M; Foreman Barbara J; Larson Dirk R; Colby Colin L; Phelps Tara K; Dispenzieri Angela; Kumar Shaji K; Katzmann Jerry A; Rajkumar S Vincent
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
Blood 2009;114(4):785-90.
2009: Kyle Robert A; Jacobus Susanna; Friedenberg William R; Slabber Coenraad Frederik; Rajkumar S Vincent; Greipp Philip R
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.
Cancer 2009;115(10):2155-64.
2009: Kyle Robert A; Benson Joanne; Larson Dirk; Therneau Terry; Dispenzieri Angela; Melton Iii L Joseph; Rajkumar S Vincent
IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 2009;9(1):17-8.
2009: Bryce Alan H; Ketterling Rhett P; Gertz Morie A; Lacy Martha; Knudson Ryan A; Zeldenrust Steven; Kumar Shaji; Hayman Suzanne; Buadi Francis; Kyle Robert A; Greipp Philip R; Lust John A; Russell Stephen; Rajkumar S Vincent; Fonseca Rafael; Dispenzieri Angela
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
Haematologica 2009;94(3):380-6.
2009: Lust John A; Lacy Martha Q; Zeldenrust Steven R; Dispenzieri Angela; Gertz Morie A; Witzig Thomas E; Kumar Shaji; Hayman Suzanne R; Russell Stephen J; Buadi Francis K; Geyer Susan M; Campbell Megan E; Kyle Robert A; Rajkumar S Vincent; Greipp Philip R; Kline Michael P; Xiong Yuning; Moon-Tasson Laurie L; Donovan Kathleen A
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.
Mayo Clinic proceedings. Mayo Clinic 2009;84(2):114-22.
2009: Kyle R A; Rajkumar S V
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(1):3-9.
2008: Bryce Alan H; Ketterling Rhett P; Gertz Morie A; Lacy Martha; Knudson Ryan A; Kumar Shaji; Kyle Robert A; Fonseca Rafael; Greipp Phillip R; Lust John A; Rajkumar Vincent S; Hayman Suzanne R; Buadi Francis; Russell Stephen J; Zeldenrust Stephen R; Dispenzieri Angela
A novel report of cig-FISH and cytogenetics in POEMS syndrome.
American journal of hematology 2008;83(11):840-1.
2008: Kumar Shaji; Pérez Waleska S; Zhang Mei-Jie; Ballen Karen; Bashey Asad; To L Bik; Bredeson Christopher N; Cairo Mitchell S; Elfenbein Gerald J; Freytes César O; Gale Robert Peter; Gibson John; Kyle Robert A; Lacy Martha Q; Lazarus Hillard M; McCarthy Philip L; Milone Gustavo A; Moreb Jan S; Pavlovsky Santiago; Reece Donna E; Vesole David H; Wiernik Peter H; Hari Parameswaran
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(10):1134-40.
2008: Snozek C L H; Katzmann J A; Kyle R A; Dispenzieri A; Larson D R; Therneau T M; Melton L J; Kumar S; Greipp P R; Clark R J; Rajkumar S V
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(10):1933-7.
2008: Gertz Morie A; Lacy Martha Q; Lust John A; Greipp Philip R; Witzig Thomas E; Kyle Robert A
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
Haematologica 2008;93(9):1402-6.
2008: Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji; Kyle Robert A; Rajkumar S Vincent; Edwards Brooks S; Rodeheffer Richard J; Frantz Robert P; Kushwaha Sudhir S; Clavell Alfredo L; Dearani Joseph A; Sundt Thoralf M; Daly Richard C; McGregor Christopher G A; Gastineau Dennis A; Litzow Mark R; Gertz Morie A
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2008;27(8):823-9.
2008: Leung N; Gertz M A; Zeldenrust S R; Rajkumar S V; Dispenzieri A; Fervenza F C; Kumar S; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Hayman S R; Russell S J; Kyle R A; Winters J L
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
Kidney international 2008;73(11):1282-8.
2008: Dispenzieri Angela; Zhang Lijun; Katzmann Jerry A; Snyder Melissa; Blood Emily; Degoey Roberta; Henderson Kimberly; Kyle Robert A; Oken Martin M; Bradwell Arthur R; Greipp Philip R
Appraisal of immunoglobulin free light chain as a marker of response.
Blood 2008;111(10):4908-15.
2008: Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Kumar Shaji K; Buadi Francis; Dingli David; Litzow Mark R; Gastineau Dennis A; Inwards David J; Elliott Michelle A; Micallef Ivana N; Ansell Stephen M; Hogan William J; Porrata Luis F; Johnston Patrick A; Afessa Bekele; Bryce Alan; Kyle Robert A; Gertz Morie A
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
European journal of haematology 2008;80(5):397-406.
2008: Tiedemann R E; Gonzalez-Paz N; Kyle R A; Santana-Davila R; Price-Troska T; Van Wier S A; Chng W J; Ketterling R P; Gertz M A; Henderson K; Greipp P R; Dispenzieri A; Lacy M Q; Rajkumar S V; Bergsagel P L; Stewart A K; Fonseca R
Genetic aberrations and survival in plasma cell leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(5):1044-52.
2008: Garces-Sanchez Mercedes; Dyck Peter J; Kyle Robert A; Zeldenrust Steven; Wu Yanhong; Ladha Shafeeq S; Klein Christopher J
Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
Muscle & nerve 2008;37(4):490-5.
2008: Kyle Robert A; Rajkumar S Vincent
Multiple myeloma.
Blood 2008;111(6):2962-72.
2008: Kumar Shaji; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Leung Nelson; Zeldenrust Steve R; Buadi Francis K; Kyle Robert A; Rajkumar S Vincent; Gertz Morie A
Serum uric acid: novel prognostic factor in primary systemic amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 2008;83(3):297-303.
2008: Dispenzieri Angela; Kyle Robert A; Katzmann Jerry A; Therneau Terry M; Larson Dirk; Benson Joanne; Clark Raynell J; Melton L Joseph; Gertz Morie A; Kumar Shaji K; Fonseca Rafael; Jelinek Diane F; Rajkumar S Vincent
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.
Blood 2008;111(2):785-9.
2007: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
British journal of haematology 2007;139(5):730-43.
2007: Lacy Martha Q; Gertz Morie A; Dispenzieri Angela; Hayman Suzanne R; Geyer Susan; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Bergsagel P Leif; Stewart A Keith; Rajkumar S Vincent
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1179-84.
2007: Rajkumar S Vincent; Lacy Martha Q; Kyle Robert A
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Blood reviews 2007;21(5):255-65.
2007: Kyle Robert A; Remstein Ellen D; Therneau Terry M; Dispenzieri Angela; Kurtin Paul J; Hodnefield Janice M; Larson Dirk R; Plevak Matthew F; Jelinek Diane F; Fonseca Rafael; Melton Lee Joseph; Rajkumar S Vincent
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.
The New England journal of medicine 2007;356(25):2582-90.
2007: Snozek Christine L H; Saenger Amy K; Greipp Philip R; Bryant Sandra C; Kyle Robert A; Rajkumar S Vincent; Katzmann Jerry A
Comparison of bromcresol green and agarose protein electrophoresis for quantitation of serum albumin in multiple myeloma.
Clinical chemistry 2007;53(6):1099-103.
2007: Dispenzieri Angela; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael; Lacy Martha Q; Bergsagel P Leif; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Reeder Craig B; Lust John A; Russell Stephen J; Hayman Suzanne R; Roy Vivek; Kumar Shaji; Zeldenrust Steven R; Dalton Robert J; Stewart A Keith
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement.
Mayo Clinic proceedings. Mayo Clinic 2007;82(3):323-41.
2007: Stewart A K; Bergsagel P L; Greipp P R; Dispenzieri A; Gertz M A; Hayman S R; Kumar S; Lacy M Q; Lust J A; Russell S J; Witzig T E; Zeldenrust S R; Dingli D; Reeder C B; Roy V; Kyle R A; Rajkumar S V; Fonseca R
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):529-34.
2007: Steensma David P; Kyle Robert A
A history of the kidney in plasma cell disorders.
Contributions to nephrology 2007;153():5-24.
2006: Katzmann Jerry A; Dispenzieri Angela; Kyle Robert A; Snyder Melissa R; Plevak Matthew F; Larson Dirk R; Abraham Roshini S; Lust John A; Melton L Joseph; Rajkumar S Vincent
Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Mayo Clinic proceedings. Mayo Clinic 2006;81(12):1575-8.
2006: Chng Wee J; Schop Roelandt F; Price-Troska Tammy; Ghobrial Irene; Kay Neil; Jelinek Diane F; Gertz Morie A; Dispenzieri Angela; Lacy Martha; Kyle Robert A; Greipp Philip R; Tschumper Renee C; Fonseca Rafael; Bergsagel Peter Leif
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
Blood 2006;108(8):2755-63.
2006: Bryce Alan H; Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Inwards David J; Yasenchak Christopher A; Kumar Shaji K; Gertz Morie A
Response to rituximab in patients with type II cryoglobulinemia.
Clinical lymphoma & myeloma 2006;7(2):140-4.
2006: Schop Roelandt F J; Van Wier Scott A; Xu Ruifang; Ghobrial Irene; Ahmann Gregory J; Greipp Philip R; Kyle Robert A; Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Cancer genetics and cytogenetics 2006;169(2):150-3.
2006: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance.
British journal of haematology 2006;134(6):573-89.
2006: Dingli David; Kyle Robert A; Rajkumar S Vincent; Nowakowski Grzegorz S; Larson Dirk R; Bida John P; Gertz Morie A; Therneau Terry M; Melton L Joseph; Dispenzieri Angela; Katzmann Jerry A
Immunoglobulin free light chains and solitary plasmacytoma of bone.
Blood 2006;108(6):1979-83.
2006: Lacy Martha Q; Dispenzieri Angela; Gertz Morie A; Greipp Philip R; Gollbach Kimberly L; Hayman Suzanne R; Kumar Shaji; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E; Zeldenrust Steven R; Dingli David; Bergsagel P Lief; Fonseca Rafael; Reeder Craig B; Stewart A Keith; Roy Vivek; Dalton Robert J; Carr Alan B; Kademani Deepak; Keller Eugene E; Viozzi Christopher F; Kyle Robert A
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1047-53.
2006: Jaleel Abdul; Owen Barbara A L; Manske Michelle K; Katzmann Jerry A; Kyle Robert A; Abraham Roshini S
Bence Jones cryoglobulinuria: characterization of a urinary kappa light chain cryoglobulin.
Clinical chemistry 2006;52(7):1435-6.
2006: Bryce Alan H; Kyle Robert A; Dispenzieri Angela; Gertz Morie A
Natural history and therapy of 66 patients with mixed cryoglobulinemia.
American journal of hematology 2006;81(7):511-8.
2006: Rajkumar S Vincent; Dispenzieri Angela; Kyle Robert A
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.
Mayo Clinic proceedings. Mayo Clinic 2006;81(5):693-703.
2006: Chng W J; Santana-Dávila R; Van Wier S A; Ahmann G J; Jalal S M; Bergsagel P L; Chesi M; Trendle M C; Jacobus S; Blood E; Oken M M; Henderson K; Kyle R A; Gertz M A; Lacy M Q; Dispenzieri A; Greipp P R; Fonseca R
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(5):807-13.
2006: Chng Wee J; Ahmann Greg J; Henderson Kim; Santana-Davila Rafael; Greipp Philip R; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Kumar Shaji; Rajkumar S Vincent; Lust John A; Kyle Robert A; Zeldenrust Steven R; Hayman Suzanne R; Fonseca Rafael
Clinical implication of centrosome amplification in plasma cell neoplasm.
Blood 2006;107(9):3669-75.
2006: Dispenzieri Angela; Lacy Martha Q; Katzmann Jerry A; Rajkumar S Vincent; Abraham Roshini S; Hayman Suzanne R; Kumar Shaji K; Clark Raynell; Kyle Robert A; Litzow Mark R; Inwards David J; Ansell Stephen M; Micallef Ivana M; Porrata Luis F; Elliott Michelle A; Johnston Patrick B; Greipp Philip R; Witzig Thomas E; Zeldenrust Steven R; Russell Stephen J; Gastineau Dennis; Gertz Morie A
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2006;107(8):3378-83.
2006: Elsawa Sherine F; Novak Anne J; Grote Deanna M; Ziesmer Steven C; Witzig Thomas E; Kyle Robert A; Dillon Stacey R; Harder Brandon; Gross Jane A; Ansell Stephen M
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
Blood 2006;107(7):2882-8.
2006: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Larson Dirk R; Plevak Matthew F; Offord Janice R; Dispenzieri Angela; Katzmann Jerry A; Melton L Joseph
Prevalence of monoclonal gammopathy of undetermined significance.
The New England journal of medicine 2006;354(13):1362-9.
2006: Chng W J; Winkler J M; Greipp P R; Jalal S M; Bergsagel P L; Chesi M; Trendle M C; Ahmann G J; Henderson K; Blood E; Oken M M; Hulbert A; Van Wier S A; Santana-Dávila R; Kyle R A; Gertz M A; Lacy M Q; Dispenzieri A; Fonseca R
Ploidy status rarely changes in myeloma patients at disease progression.
Leukemia research 2006;30(3):266-71.
2006: Kyle Robert A; Vincent Rajkumar S
Treatment of multiple myeloma: an emphasis on new developments.
Annals of medicine 2006;38(2):111-5.
2005: Dingli David; Rajkumar S Vincent; Nowakowski Grzegorz S; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne; Fonseca Rafael; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Haematologica 2005;90(12):1650-4.
2005: Rajkumar S Vincent; Hayman Suzanne R; Lacy Martha Q; Dispenzieri Angela; Geyer Susan M; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Gertz Morie A
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
Blood 2005;106(13):4050-3.
2005: Rajkumar S Vincent; Kyle Robert A
Multiple myeloma: diagnosis and treatment.
Mayo Clinic proceedings. Mayo Clinic 2005;80(10):1371-82.
2005: Nowakowski Grzegorz S; Witzig Thomas E; Dingli David; Tracz Michal J; Gertz Morie A; Lacy Martha Q; Lust John A; Dispenzieri Angela; Greipp Philip R; Kyle Robert A; Rajkumar S Vincent
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.
Blood 2005;106(7):2276-9.
2005: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance.
Clinical lymphoma & myeloma 2005;6(2):102-14.
2005: Chng Wee Joo; Van Wier Scott A; Ahmann Gregory J; Winkler Jerry M; Jalal Syed M; Bergsagel Peter Leif; Chesi Marta; Trendle Mike C; Oken Martin M; Blood Emily; Henderson Kim; Santana-Dávila Rafael; Kyle Robert A; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Fonseca Rafael
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
Blood 2005;106(6):2156-61.
2005: Rajkumar S Vincent; Kyle Robert A; Therneau Terry M; Melton L Joseph; Bradwell Arthur R; Clark Raynell J; Larson Dirk R; Plevak Matthew F; Dispenzieri Angela; Katzmann Jerry A
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.
Blood 2005;106(3):812-7.
2005: Katzmann Jerry A; Abraham Roshini S; Dispenzieri Angela; Lust John A; Kyle Robert A
Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Clinical chemistry 2005;51(5):878-81.
2005: Kyle Robert A; Rajkumar S Vincent; Therneau Terry M; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance.
Clinical lymphoma 2005;5(4):257-60.
2005: Melton L Joseph; Kyle Robert A; Achenbach Sara J; Oberg Ann L; Rajkumar S Vincent
Fracture risk with multiple myeloma: a population-based study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(3):487-93.
2005: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathies of undetermined significance.
Best practice & research. Clinical haematology 2005;18(4):689-707.
2005: Rajkumar S Vincent; Kyle Robert A
Conventional therapy and approach to management.
Best practice & research. Clinical haematology 2005;18(4):585-601.
2004: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades.
Cancer 2004;101(11):2667-74.
2004: Rajkumar S Vincent; Kyle Robert A; Therneau Terry M; Clark Raynell J; Bradwell Arthur R; Melton L Joseph; Larson Dirk R; Plevak Matthew F; Katzmann Jerry A
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
British journal of haematology 2004;127(3):308-10.
2004: Dispenzieri Angela; Moreno-Aspitia Alvaro; Suarez Guillermo A; Lacy Martha Q; Colon-Otero Gerardo; Tefferi Ayalew; Litzow Mark R; Roy Vivek; Hogan William J; Kyle Robert A; Gertz Morie A
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature.
Blood 2004;104(10):3400-7.
2004: Kyle Robert A; Rajkumar S Vincent
Multiple myeloma.
The New England journal of medicine 2004;351(18):1860-73.
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; Greipp Philip R; Witzig Thomas E; Lust John A; Rajkumar S Vincent; Fonseca Rafael; Zeldenrust Steven R; McGregor Christopher G A; Jaffe Allan S
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3751-7.
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma.
Bone marrow transplantation 2004;34(6):485-90.
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; McConnell Joseph P; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Hogan William J; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; McGregor Christopher G A; Jaffe Allan S
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2004;104(6):1881-7.
2004: Kumar S; Gertz M A; Dispenzieri A; Lacy M Q; Wellik L A; Fonseca R; Lust J A; Witzig T E; Kyle R A; Greipp P R; Rajkumar S V
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
Bone marrow transplantation 2004;34(3):235-9.
2004: Kumar Shaji K; Therneau Terry M; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Rajkumar S Vincent; Fonseca Rafael; Witzig Thomas E; Lust John A; Larson Dirk R; Kyle Robert A; Greipp Philip R
Clinical course of patients with relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):867-74.
2004: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):859-66.
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy.
Bone marrow transplantation 2004;34(2):161-7.
2004: Ma Cynthia X; Lacy Martha Q; Rompala John F; Dispenzieri Angela; Rajkumar S Vincent; Greipp Philip R; Fonseca Rafael; Kyle Robert A; Gertz Morie A
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma.
Blood 2004;104(1):40-2.
2004: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Therneau Terry M; Larson Dirk R; Plevak Matthew F; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Gertz Morie A
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
Blood 2004;103(10):3960-3.
2004: Kumar S; Witzig T E; Dispenzieri A; Lacy M Q; Wellik L E; Fonseca R; Lust J A; Gertz M A; Kyle R A; Greipp P R; Rajkumar S V
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):624-7.
2004: Melton L Joseph; Rajkumar S Vincent; Khosla Sundeep; Achenbach Sara J; Oberg Ann L; Kyle Robert A
Fracture risk in monoclonal gammopathy of undetermined significance.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(1):25-30.
2003: Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Geyer Susan M; Witzig Thomas E; Fonseca Rafael; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(4):257-61.
2003: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Remstein Ellen D; Offord Janice R; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
Blood 2003;102(10):3759-64.
2003: Fonseca Rafael; Debes-Marun Carina S; Picken Elisa B; Dewald Gordon W; Bryant Sandra C; Winkler Jerry M; Blood Emily; Oken Martin M; Santana-Dávila Rafael; González-Paz Natalia; Kyle Robert A; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
Blood 2003;102(7):2562-7.
2003: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathies of undetermined significance: a review.
Immunological reviews 2003;194():112-39.
2003: Fonseca Rafael; Blood Emily; Rue Montserrat; Harrington David; Oken Martin M; Kyle Robert A; Dewald Gordon W; Van Ness Brian; Van Wier Scott A; Henderson Kimberly J; Bailey Richard J; Greipp Philip R
Clinical and biologic implications of recurrent genomic aberrations in myeloma.
Blood 2003;101(11):4569-75.
2003: Abraham Roshini S; Geyer Susan M; Price-Troska Tammy L; Allmer Cristine; Kyle Robert A; Gertz Morie A; Fonseca Rafael
Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).
Blood 2003;101(10):3801-8.
2003: Remstein Ellen D; Hanson Curtis A; Kyle Robert A; Hodnefield Janice M; Kurtin Paul J
Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
Seminars in oncology 2003;30(2):182-6.
2003: Kyle R A; Therneau T M; Rajkumar S V; Offord J R; Larson D R; Plevak M F; Melton L J
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
Seminars in oncology 2003;30(2):169-71.
2003: Rajkumar S V; Gertz M A; Lacy M Q; Dispenzieri A; Fonseca R; Geyer S M; Iturria N; Kumar S; Lust J A; Kyle R A; Greipp P R; Witzig T E
Thalidomide as initial therapy for early-stage myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(4):775-9.
2003: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Therneau Terry M; Larson Dirk R; Greipp Philip R; Witzig Thomas E; Basu Rita; Suarez Guillermo A; Fonseca Rafael; Lust John A; Gertz Morie A
POEMS syndrome: definitions and long-term outcome.
Blood 2003;101(7):2496-506.
2003: Kyle Robert A; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela
Localized AL amyloidosis of the colon: an unrecognized entity.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(1):36-41.
2003: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Wellik Linda; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Prognostic value of angiogenesis in solitary bone plasmacytoma.
Blood 2003;101(5):1715-7.
2003: Debes-Marun C S; Dewald G W; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler J M; Kyle R A; Gertz M A; Witzig T E; Dispenzieri A; Lacy M Q; Rajkumar S V; Lust J A; Greipp P R; Fonseca R
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):427-36.
2003: Abraham Roshini S; Katzmann Jerry A; Clark Raynell J; Bradwell A R; Kyle Robert A; Gertz Morie A
Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.
American journal of clinical pathology 2003;119(2):274-8.
2003: Pardanani Animesh; Witzig Thomas E; Schroeder Georgene; McElroy Edwin A; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Kyle Robert A; Greipp Philip R; Gertz Morie A; Rajkumar S Vincent
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis.
Blood 2003;101(3):827-30.
2003: Kumar Shaji; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Geyer Susan M; Iturria Nancy L; Fonseca Rafael; Hayman Suzanne R; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Rajkumar S Vincent
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):34-9.
2003: Kyle Robert A; Gertz Morie A; Witzig Thomas E; Lust John A; Lacy Martha Q; Dispenzieri Angela; Fonseca Rafael; Rajkumar S Vincent; Offord Janice R; Larson Dirk R; Plevak Matthew E; Therneau Terry M; Greipp Philip R
Review of 1027 patients with newly diagnosed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):21-33.
2002: Rajkumar S Vincent; Kyle Robert A; Gertz Morie A
Myeloma and the newly diagnosed patient: a focus on treatment and management.
Seminars in oncology 2002;29(6 Suppl 17):5-10.
2002: Andrews Tricia R; Colon-Otero Gerardo; Calamia Kenneth T; Menke David M; Boylan Kevin B; Kyle Robert A
Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy.
Mayo Clinic proceedings. Mayo Clinic 2002;77(12):1287-90.
2002: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Bone marrow angiogenesis in multiple myeloma: effect of therapy.
British journal of haematology 2002;119(3):665-71.
2002: Rajkumar S Vincent; Hayman Suzanne; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R; Geyer Susan; Iturria Nancy; Fonseca Rafael; Lust John A; Kyle Robert A; Witzig Thomas E
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4319-23.
2002: Schop Roelandt F J; Kuehl W Michael; Van Wier Scott A; Ahmann Gregory J; Price-Troska Tammy; Bailey Richard J; Jalal Syed M; Qi Ying; Kyle Robert A; Greipp Philip R; Fonseca Rafael
Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
Blood 2002;100(8):2996-3001.
2002: Abraham Roshini S; Charlesworth M Cristine; Owen Barbara A L; Benson Linda M; Katzmann Jerry A; Reeder Craig B; Kyle Robert A
Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma.
Clinical chemistry 2002;48(10):1805-11.
2002: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathies of undetermined significance.
Reviews in clinical and experimental hematology 2002;6(3):225-52.
2002: Katzmann Jerry A; Clark Raynell J; Abraham Roshini S; Bryant Sandra; Lymp James F; Bradwell Arthur R; Kyle Robert A
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Clinical chemistry 2002;48(9):1437-44.
2002: Rajkumar S Vincent; Gertz Morie A; Kyle Robert A; Greipp Philip R;
Current therapy for multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2002;77(8):813-22.
2002: Fonseca Rafael; Bailey Richard J; Ahmann Gregory J; Rajkumar S Vincent; Hoyer James D; Lust John A; Kyle Robert A; Gertz Morie A; Greipp Philip R; Dewald Gordon W
Genomic abnormalities in monoclonal gammopathy of undetermined significance.
Blood 2002;100(4):1417-24.
2002: Rajkumar S Vincent; Mesa Ruben A; Fonseca Rafael; Schroeder Georgene; Plevak Matthew F; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Russell Stephen J; Greipp Philip R
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2210-6.
2002: Fonseca Rafael; Blood Emily A; Oken Martin M; Kyle Robert A; Dewald Gordon W; Bailey Richard J; Van Wier Scott A; Henderson Kimberly J; Hoyer James D; Harrington David; Kay Neil E; Van Ness Brian; Greipp Philip R
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.
Blood 2002;99(10):3735-41.
2002: Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Cheson Bruce D; Barlogie Bart; Kyle Robert A; Palladini Giovanni; Geyer Susan M; Merlini Giampaolo
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2002;9(1):24-30.
2002: Kyle Robert A
Current therapy of multiple myeloma.
Internal medicine (Tokyo, Japan) 2002;41(3):175-80.
2002: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Offord Janice R; Larson Dirk R; Plevak Matthew F; Melton L Joseph
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
The New England journal of medicine 2002;346(8):564-9.
2002: Schop Roelandt F J; Jalal Syed M; Van Wier Scott A; Ahmann Gregory J; Bailey Richard J; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent; Gertz Morie A; Lust John A; Lacy Martha Q; Dispenzieri Angela; Witzig Thomas E; Fonseca Rafael
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
Cancer genetics and cytogenetics 2002;132(1):55-60.
2002: Abraham Roshini S; Clark Raynell J; Bryant Sandra C; Lymp James F; Larson Timothy; Kyle Robert A; Katzmann Jerry A
Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
Clinical chemistry 2002;48(4):655-7.
2001: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Therneau T M; Kyle R A; Greipp P R; Gertz M A
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation.
American journal of hematology 2001;68(4):269-75.
2001: Kyle R A; Rajkumar S V
Therapeutic application of thalidomide in multiple myeloma.
Seminars in oncology 2001;28(6):583-7.
2001: Rajkumar S V; Kyle R A
Angiogenesis in multiple myeloma.
Seminars in oncology 2001;28(6):560-4.
2001: Kyle R A
Henry Bence Jones--physician, chemist, scientist and biographer: a man for all seasons.
British journal of haematology 2001;115(1):13-8.
2001: Hayman S R; Bailey R J; Jalal S M; Ahmann G J; Dispenzieri A; Gertz M A; Greipp P R; Kyle R A; Lacy M Q; Rajkumar S V; Witzig T E; Lust J A; Fonseca R
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis.
Blood 2001;98(7):2266-8.
2001: Kyle R A
Amyloidosis: a convoluted story.
British journal of haematology 2001;114(3):529-38.
2001: Rajkumar S V; Dispenzieri A; Fonseca R; Lacy M Q; Geyer S; Lust J A; Kyle R A; Greipp P R; Gertz M A; Witzig T E
Thalidomide for previously untreated indolent or smoldering multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(8):1274-6.
2001: Dispenzieri A; Lacy M Q; Kyle R A; Therneau T M; Larson D R; Rajkumar S V; Fonseca R; Greipp P R; Witzig T E; Lust J A; Gertz M A
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3350-6.
2001: Kyle R A
Management of patients with multiple myeloma: emphasizing the role of high-dose therapy.
Clinical lymphoma 2001;2(1):21-8.
2001: Dispenzieri A; Gertz M A; Therneau T M; Kyle R A
Retrospective cohort study of 148 patients with polyclonal gammopathy.
Mayo Clinic proceedings. Mayo Clinic 2001;76(5):476-87.
2001: Steensma D P; Gertz M A; Greipp P R; Kyle R A; Lacy M Q; Lust J A; Offord J R; Plevak M F; Therneau T M; Witzig T E
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.
Blood 2001;97(8):2522-3.
2000: Kyle R A
Multiple myeloma: an odyssey of discovery.
British journal of haematology 2000;111(4):1035-44.
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Witzig T E; Lust J A; Larson D; Therneau T M; Kyle R A; Litzow M R; Greipp P R; Gertz M A
Effect of complete response on outcome following autologous stem cell transplantation for myeloma.
Bone marrow transplantation 2000;26(9):979-83.
2000: Gertz M A; Lacy M Q; Gastineau D A; Inwards D J; Chen M G; Tefferi A; Kyle R A; Litzow M R
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL).
Bone marrow transplantation 2000;26(9):963-9.
2000: Fonseca R; Rajkumar S V; Ahmann G J; Jalal S M; Hoyer J D; Gertz M A; Kyle R A; Greipp P R; Dewald G W
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis.
Leukemia & lymphoma 2000;39(3-4):391-5.
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Thalidomide in the treatment of relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2000;75(9):897-901.
2000: Rajkumar S V; Leong T; Roche P C; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Prognostic value of bone marrow angiogenesis in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3111-6.
2000: Fonseca R; Trendle M C; Leong T; Kyle R A; Oken M M; Kay N E; Van Ness B; Greipp P R
Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients.
British journal of haematology 2000;109(1):24-9.
2000: Grogan M; Gertz M A; Kyle R A; Tajik A J
Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement.
The American journal of cardiology 2000;85(5):664-5, A11.
2000: Kyle R A; Greipp P R; Gertz M A; Witzig T E; Lust J A; Lacy M Q; Therneau T M
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.
British journal of haematology 2000;108(4):737-42.
1999: Kyle R A; Rajkumar S V
Monoclonal gammopathies of undetermined significance.
Hematology/oncology clinics of North America 1999;13(6):1181-202.
1999: Fonseca R; Hoyer J D; Aguayo P; Jalal S M; Ahmann G J; Rajkumar S V; Witzig T E; Lacy M Q; Dispenzieri A; Gertz M A; Kyle R A; Greipp P R
Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
Leukemia & lymphoma 1999;35(5-6):599-605.
1999: Kyle R A
Maintenance therapy and supportive care for patients with multiple myeloma.
Seminars in oncology 1999;26(5 Suppl 13):35-42.
1999: Greipp P R; Trendle M C; Leong T; Oken M M; Kay N E; Van Ness B; Kyle R A
Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
Leukemia & lymphoma 1999;35(1-2):83-9.
1999: Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Bone marrow transplantation 1999;24(5):497-503.
1999: Rajkumar S V; Fonseca R; Dewald G W; Therneau T M; Lacy M Q; Kyle R A; Greipp P R; Gertz M A
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
Cancer genetics and cytogenetics 1999;113(1):73-7.
1999: Trendle M C; Leong T; Kyle R A; Katzmann J A; Oken M M; Kay N E; Van Ness B G; Greipp P R
Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486.
American journal of hematology 1999;61(4):232-7.
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Autologous stem cell transplantation for relapsed and primary refractory myeloma.
Bone marrow transplantation 1999;23(12):1267-72.
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.
Bone marrow transplantation 1999;23(12):1261-6.
1999: Gertz M A; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Kyle R A
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.
American journal of hematology 1999;61(2):115-9.
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Therneau T M; Kyle R A; Litzow M R; Gertz M A; Greipp P R
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1551-7.
1999: Shampo M A; Kyle R A
Hans Spemann--contributions to embryology.
Mayo Clinic proceedings. Mayo Clinic 1999;74(5):474.
1999: Daoud M S; Lust J A; Kyle R A; Pittelkow M R
Monoclonal gammopathies and associated skin disorders.
Journal of the American Academy of Dermatology 1999;40(4):507-35; quiz 536-8.
1999: Kyle R A
Clinical aspects of multiple myeloma and related disorders including amyloidosis.
Pathologie-biologie 1999;47(2):148-57.
1999: Gertz M A; Lacy M Q; Inwards D J; Chen M G; Pineda A A; Gastineau D A; Greipp P R; Lust J A; Tefferi A; Witzig T E; Kyle R A; Litzow M R
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Bone marrow transplantation 1999;23(3):221-6.
1999: Kyle R A
High-dose therapy in multiple myeloma and primary amyloidosis: an overview.
Seminars in oncology 1999;26(1):74-83.
1999: Kyle R A
Sequence of testing for monoclonal gammopathies.
Archives of pathology & laboratory medicine 1999;123(2):114-8.
1999: Kyle R A; Gertz M A; Greipp P R; Witzig T E; Lust J A; Lacy M Q; Therneau T M
Long-term survival (10 years or more) in 30 patients with primary amyloidosis.
Blood 1999;93(3):1062-6.
1999: Gertz M A; Lacy M Q; Lust J A; Greipp P R; Witzig T E; Kyle R A
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):262-7.
1998: Fonseca R; Ahmann G J; Jalal S M; Dewald G W; Larson D R; Therneau T M; Gertz M A; Kyle R A; Greipp P R
Chromosomal abnormalities in systemic amyloidosis.
British journal of haematology 1998;103(3):704-10.
1998: Clark R; Katzmann J A; Kyle R A; Fleisher M; Landers J P
Differential diagnosis of gammopathies by capillary electrophoresis and immunosubtraction: analysis of serum samples problematic by agarose gel electrophoresis.
Electrophoresis 1998;19(14):2479-84.
1998: Katzmann J A; Clark R; Sanders E; Landers J P; Kyle R A
Prospective study of serum protein capillary zone electrophoresis and immunotyping of monoclonal proteins by immunosubtraction.
American journal of clinical pathology 1998;110(4):503-9.
1998: Bladé J; Kyle R A
Multiple myeloma in young patients: clinical presentation and treatment approach.
Leukemia & lymphoma 1998;30(5-6):493-501.
1998: Fonseca R; Witzig T E; Gertz M A; Kyle R A; Hoyer J D; Jalal S M; Greipp P R
Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
British journal of haematology 1998;101(2):296-301.
1998: Mongkonsritragoon W; Kyle R A; Shreck R R; Greipp P R
Primary plasmacytoma at the site of exit wounds after electrical injury.
American journal of hematology 1998;58(1):77-9.
1998: Donovan K A; Lacy M Q; Kline M P; Ahmann G J; Heimbach J K; Kyle R A; Lust J A
Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(4):593-600.
1998: Rajkumar S V; Gertz M A; Kyle R A
Primary systemic amyloidosis with delayed progression to multiple myeloma.
Cancer 1998;82(8):1501-5.
1998: Greipp P R; Leong T; Bennett J M; Gaillard J P; Klein B; Stewart J A; Oken M M; Kay N E; Van Ness B; Kyle R A
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.
Blood 1998;91(7):2501-7.
1998: McElroy E A; Witzig T E; Gertz M A; Greipp P R; Kyle R A
Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis.
British journal of haematology 1998;100(2):326-7.
1997: Lacy M Q; Gertz M A; Hanson C A; Inwards D J; Kyle R A
Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome).
American journal of hematology 1997;56(4):288-93.
1997: Katzmann J A; Clark R; Wiegert E; Sanders E; Oda R P; Kyle R A; Namyst-Goldberg C; Landers J P
Identification of monoclonal proteins in serum: a quantitative comparison of acetate, agarose gel, and capillary electrophoresis.
Electrophoresis 1997;18(10):1775-80.
1997: Gertz M A; Lacy M Q; Inwards D J; Pineda A A; Chen M G; Gastineau D A; Tefferi A; Kyle R A; Litzow M R
Factors influencing platelet recovery after blood cell transplantation in multiple myeloma.
Bone marrow transplantation 1997;20(5):375-80.
1997: Gertz M A; Grogan M; Kyle R A; Tajik A J
Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy.
The American journal of cardiology 1997;80(1):93-5.
1997: Kyle R A; Shampo M A
Thomas Huckle Weller and the successful culture of poliovirus.
Mayo Clinic proceedings. Mayo Clinic 1997;72(5):422.
1997: Kyle R A; Gertz M A; Greipp P R; Witzig T E; Lust J A; Lacy M Q; Therneau T M
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
The New England journal of medicine 1997;336(17):1202-7.
1997: Kyle R A
Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.
Hematology/oncology clinics of North America 1997;11(1):71-87.
1997: Gertz M A; Witzig T E; Pineda A A; Greipp P R; Kyle R A; Litzow M R
Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation.
Bone marrow transplantation 1997;19(4):337-42.
1996: Kyle R A; Shampo M A
Stamp vignette on medical science. Percy Lavon Julian--industrial chemist.
Mayo Clinic proceedings. Mayo Clinic 1996;71(12):1170.
1996: Kyle R A; Spittell P C; Gertz M A; Li C Y; Edwards W D; Olson L J; Thibodeau S N
The premortem recognition of systemic senile amyloidosis with cardiac involvement.
The American journal of medicine 1996;101(4):395-400.
1996: Liu P; Leong T; Quam L; Billadeau D; Kay N E; Greipp P; Kyle R A; Oken M M; Van Ness B
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.
Blood 1996;88(7):2699-706.
1996: Badley A D; Portela D F; Patel R; Kyle R A; Habermann T M; Strickler J G; Ilstrup D M; Wiesner R H; de Groen P; Walker R C; Paya C V
Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1996;2(5):375-82.
1996: Witzig T E; Gertz M A; Lust J A; Kyle R A; O'Fallon W M; Greipp P R
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
Blood 1996;88(5):1780-7.
1996: Billadeau D; Van Ness B; Kimlinger T; Kyle R A; Therneau T M; Greipp P R; Witzig T E
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.
Blood 1996;88(1):289-96.
1996: Bladé J; Kyle R A; Greipp P R
Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature.
Archives of internal medicine 1996;156(13):1463-8.
1996: Kyle R A; Shampo M A
Hans von Euler-Chelpin--Noble laureate.
Mayo Clinic proceedings. Mayo Clinic 1996;71(6):596.
1996: Bladé J; Kyle R A; Greipp P R
Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years.
British journal of haematology 1996;93(2):345-51.
1996: Oken M M; Kyle R A; Greipp P R; Kay N E; Tsiatis A; Gregory S A; Spiegel R J; O'Connell M J
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
Leukemia & lymphoma 1996;20(5-6):447-52.
1996: Shampo M A; Kyle R A
David Hubel--Nobel Prize winner for investigations of brain function.
Mayo Clinic proceedings. Mayo Clinic 1996;71(2):116.
1996: Kyle R A
Monoclonal gammopathy of undetermined significance.
Current topics in microbiology and immunology 1996;210():375-83.
1995: Kyle R A
Monoclonal gammopathy of undetermined significance (MGUS).
Baillière's clinical haematology 1995;8(4):761-81.
1995: Gertz M A; Garton J P; Greipp P R; Witzig T E; Kyle R A
A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(12):2115-8.
1995: Witzig T E; Gertz M A; Lust J A; Kyle R A; Greipp P R
Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?
Leukemia & lymphoma 1995;19(5-6):417-22.
1995: Kay N E; Oken M M; Bone N; Kyle R A; Greipp P; Van Ness B; Leong T
Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group.
Blood 1995;86(10):4000-1.
1995: Garton J P; Gertz M A; Witzig T E; Greipp P R; Lust J A; Schroeder G; Kyle R A
Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
Archives of internal medicine 1995;155(19):2069-74.
1995: Kyle R A
Prognostic factors in multiple myeloma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():56-63.
1995: Mathew P; Ahmann G J; Witzig T E; Roche P C; Kyle R A; Greipp P R
Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?
British journal of haematology 1995;90(2):459-61.
1995: Witzig T E; Gertz M A; Pineda A A; Kyle R A; Greipp P R
Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma.
British journal of haematology 1995;89(3):640-2.
1995: Kyle R A; Gertz M A
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
Seminars in hematology 1995;32(1):45-59.
1995: Kay N E; Oken M M; Kyle R; Van Ness B; Kalish L; Leong T; Greipp P
Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cells.
Leukemia & lymphoma 1995;16(3-4):351-4.
1994: Bladé J; Lust J A; Kyle R A
Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2398-404.
1994: Kyle R A
The monoclonal gammopathies.
Clinical chemistry 1994;40(11 Pt 2):2154-61.
1994: Gertz M A; Kyle R A
Amyloidosis: prognosis and treatment.
Seminars in arthritis and rheumatism 1994;24(2):124-38.
1994: Kyle R A
Monoclonal gammopathy of undetermined significance.
Blood reviews 1994;8(3):135-41.
1994: Kyle R A; Beard C M; O'Fallon W M; Kurland L T
Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1577-83.
1994: Kyle R A
Multiple myeloma: how did it begin?
Mayo Clinic proceedings. Mayo Clinic 1994;69(7):680-3.
1994: Witzig T E; Kyle R A; O'Fallon W M; Greipp P R
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma.
British journal of haematology 1994;87(2):266-72.
1994: Kyle R A
Monoclonal proteins and renal disease.
Annual review of medicine 1994;45():71-7.
1993: Jelinek D F; Ahmann G J; Greipp P R; Jalal S M; Westendorf J J; Katzmann J A; Kyle R A; Lust J A
Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
Cancer research 1993;53(21):5320-7.
1993: Witzig T E; Dhodapkar M V; Kyle R A; Greipp P R
Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma.
Cancer 1993;72(1):108-13.
1993: Greipp P R; Lust J A; O'Fallon W M; Katzmann J A; Witzig T E; Kyle R A
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.
Blood 1993;81(12):3382-7.
1993: Gertz M A; Noël P; Kyle R A
Second malignancies after chemotherapy and transplantation.
Critical reviews in oncology/hematology 1993;14(2):107-25.
1993: Kyle R A
"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.
Mayo Clinic proceedings. Mayo Clinic 1993;68(1):26-36.
1992: Billadeau D; Quam L; Thomas W; Kay N; Greipp P; Kyle R; Oken M M; Van Ness B
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.
Blood 1992;80(7):1818-24.
1992: Kyle R A
Monoclonal proteins in neuropathy.
Neurologic clinics 1992;10(3):713-34.
1992: Kyle R A
Current concepts on monoclonal gammopathies.
Australian and New Zealand journal of medicine 1992;22(3):291-302.
1992: Droder R M; Kyle R A; Greipp P R
Control of systemic capillary leak syndrome with aminophylline and terbutaline.
The American journal of medicine 1992;92(5):523-6.
1992: Kyle R A
Diagnostic criteria of multiple myeloma.
Hematology/oncology clinics of North America 1992;6(2):347-58.
1992: Kyle R A; Linos A; Beard C M; Linke R P; Gertz M A; O'Fallon W M; Kurland L T
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.
Blood 1992;79(7):1817-22.
1992: Lust J A; Donovan K A; Kline M P; Greipp P R; Kyle R A; Maihle N J
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.
Cytokine 1992;4(2):96-100.
1992: Witzig T E; Kyle R A; Greipp P R
Circulating peripheral blood plasma cells in multiple myeloma.
Current topics in microbiology and immunology 1992;182():195-9.
1991: Billadeau D; Blackstadt M; Greipp P; Kyle R A; Oken M M; Kay N; Van Ness B
Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease.
Blood 1991;78(11):3021-9.
1991: Oken M M; Kyle R A
Strategies for combining interferon with chemotherapy for the treatment of multiple myeloma.
Seminars in oncology 1991;18(5 Suppl 7):30-2.
1991: Gastineau D A; Gertz M A; Rosen C B; Kyle R A
Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis.
American journal of hematology 1991;37(3):194-6.
1991: Gastineau D A; Gertz M A; Daniels T M; Kyle R A; Bowie E J
Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality.
Blood 1991;77(12):2637-40.
1990: Kyle R A; Lust J A
The monoclonal gammopathies (paraproteins).
Advances in clinical chemistry 1990;28():145-218.
1989: Litzow M R; Kyle R A
Multiple responses of aplastic anemia to low-dose cyclosporine therapy despite development of a myelodysplastic syndrome.
American journal of hematology 1989;32(3):226-9.
1989: Kyle R A; Lust J A
Monoclonal gammopathies of undetermined significance.
Seminars in hematology 1989;26(3):176-200.
1989: Kyle R A
Monoclonal gammopathies and the kidney.
Annual review of medicine 1989;40():53-60.
1988: Kyle R A
IgD multiple myeloma: a cure at 21 years.
American journal of hematology 1988;29(1):41-3.
1988: Greipp P R; Katzmann J A; O'Fallon W M; Kyle R A
Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma.
Blood 1988;72(1):219-23.
1988: Gertz M A; Li C Y; Shirahama T; Kyle R A
Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain).
Archives of internal medicine 1988;148(4):929-33.
1987: Gertz M A; Petitt R M; Perrault J; Kyle R A
Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 1987;62(12):1095-100.
1987: Noel P; Kyle R A
Plasma cell leukemia: an evaluation of response to therapy.
The American journal of medicine 1987;83(6):1062-8.
1986: Gertz M A; Garton J P; Kyle R A
Primary amyloidosis (AL) in families.
American journal of hematology 1986;22(2):193-8.
1985: Kyle R A; Greipp P R; Garton J P; Gertz M A
Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine.
The American journal of medicine 1985;79(6):708-16.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Robert Kyle

Research Profile (preview)

Disorders

Anatomy

Concepts & Ideas

Physiology

Chemicals & Drugs

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Robert Kyle (preview)

All Publications